|
Carboplatin (or cisplatin if carboplatin is not tolerated) Clinical Trials
1 actively recruiting trial across 1 location
No change since June 2026
Pipeline
Phase 3: 1
Top Sponsors
- BioNTech SE1
Indications
- Extensive Stage-small Cell Lung Cancer1
- Lung Cancer1
- Cancer1
Tucson, Arizona1 trial
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
ACRC Arizona Clinical Research Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.